hexamethonium has been researched along with Hypovolemic in 1 studies
Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Palheta, RC | 1 |
Silva, MT | 1 |
Barbosa, HL | 1 |
Pinheiro, AD | 1 |
Cardoso, KV | 1 |
Graça, JR | 1 |
Magalhães, PJ | 1 |
Oliveira, RB | 1 |
Santos, AA | 1 |
1 other study available for hexamethonium and Hypovolemic
Article | Year |
---|---|
Atrial stretch delays gastric emptying of liquids in awake rats.
Topics: Analysis of Variance; Animals; Atrial Function, Right; Atropine; Balloon Occlusion; Blood Pressure; | 2013 |